SCHEMBL25775357

SCHEMBL25775357

N#Cc1ccc(-c2cccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)c2)c(-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)cc2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 5/20 0.47
▸ CLK4 Q9HAZ1 4/20 0.47
▸ MEN1 O00255 4/20 0.47
▸ ALDH1A1 P00352 4/20 0.47
▸ KMT2A Q03164 4/20 0.47
▸ CYP3A4 P08684 4/20 0.47
▸ LMNA P02545 4/20 0.47
▸ CYP2C19 P33261 3/20 0.47
▸ HSD17B10 Q99714 3/20 0.47
▸ CYP2D6 P10635 3/20 0.47
▸ TSHR P16473 2/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ ABCG2 Q9UNQ0 10/20 0.47
▸ ABCB1 P08183 5/20 0.47
▸ MAPK1 P28482 2/20 0.44
▸ TP53 P04637 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ ABCC1 P33527 2/20 0.42
▸ ADORA3 P0DMS8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25775434 0.99 CLK4 (0.46) CYP1A2CLK4MEN1ALDH1A1KMT2A
SCHEMBL25774579 0.97 CYP1A2 (0.49) CYP1A2CLK4MEN1ALDH1A1KMT2A
SCHEMBL26553243 0.94 ABCG2 (0.48) CYP1A2CLK4MEN1ALDH1A1KMT2A
SCHEMBL26553227 0.94 CYP1A2 (0.45) CYP1A2CLK4MEN1ALDH1A1KMT2A
SCHEMBL27369382 0.94 ABCG2 (0.50) CYP1A2CLK4MEN1ALDH1A1KMT2A
SCHEMBL27369387 0.94 ABCG2 (0.50) CYP1A2CLK4MEN1ALDH1A1KMT2A
SCHEMBL27369401 0.94 ABCG2 (0.50) CYP1A2CLK4MEN1ALDH1A1KMT2A
SCHEMBL25774578 0.94 ABCG2 (0.51) CYP1A2CLK4MEN1ALDH1A1KMT2A
SCHEMBL26274336 0.93 ABCG2 (0.49) CYP1A2CLK4MEN1ALDH1A1KMT2A
SCHEMBL27369393 0.93 CYP1A2 (0.52) CYP1A2CLK4MEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230331704-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2023-10-19 — — US disclosed
US-20230331704-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2023-10-19 — — US disclosed
EP-4206195-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME Lg Chem, Ltd. (KR) 2023-07-05 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230331704-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME NR2E3, NR2E1, NR0B2 CYP1A2 91/4885CLK4 1453/4885MEN1 1557/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback